Shares of Johnson & Johnson /zigman2/quotes/201724570/composite JNJ -0.94% inched 0.89% higher to $167.57 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX -2.09% rising 0.19% to 4,305.20 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA -1.61% rising 0.71% to 34,152.01. This was the stock's second consecutive day of gains. Johnson & Johnson closed $19.12 short of its 52-week high ($186.69), which the company achieved on April 25th.
The stock outperformed some of its competitors Tuesday, as Roche Holding AG Part. Cert. /zigman2/quotes/206948568/delayed RHHVF -5.88% fell 2.56% to $327.80, Merck & Co. Inc. /zigman2/quotes/209956077/composite MRK -0.17% fell 0.01% to $90.59, and Pfizer Inc. /zigman2/quotes/202877789/composite PFE -0.77% rose 0.22% to $49.86. Trading volume (7.4 M) eclipsed its 50-day average volume of 6.7 M.